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Abstract
Background: Hyponatremia is a common and potentially life threatening problem in patients with
neuroendocrine tumors.
Case presentation: A 54-year-old female with a history of smoking and narcotic dependency
presented to her primary care physician with nausea, vomiting, fatigue, malaise, ataxia and a serum
sodium of 100 mEq/L. A chest computerized tomography (CT) revealed a 4.1 × 4.9 cm precarinal/
pretracheal mass encircling the right brachiocephalic vein. A mediastinal biopsy found a malignant,
intermediate-size small cell (oat cell) carcinoma. Saline infusion along with intravenous furosemide
successfully corrected her hyponatremia. Unfortunately, the patient later died of complications
related to her cancer and cancer therapy.
Conclusion:  Paraneoplastic hyponatremia can be severe, but even severe cases may be
successfully treated.
Introduction
Hyponatremia is a common clinical problem that when
symptomatic may manifest with nausea, disorientation,
seizures, coma, cerebral edema and even death [1]. It is
evident in approximately 15% of patients with small-cell
lung cancer [2]. The etiology of hyponatremia in small-
cell carcinoma has been attributed most often to high lev-
els of vasopressin (AVP); however, atrial natriuetic pep-
tide (ANP) has been implicated as well [3,4]. Correction
of hyponatremia is usually successful at moderately low
sodium levels, although it must be done slowly to prevent
irreversible osmotic demylination. It has been shown that
correction is more likely to be successful in persons with
higher sodium levels and that death is more likely for per-
sons with more severe hyponatremia [5].
We report a case of very severe hyponatremia related to a
neuroendocrine tumor where the patient's sodium was
successfully corrected.
Case presentation
A 54-year-old white female presented to her primary care
physician with a four-day history of nausea, vomiting,
fatigue, malaise, blurry vision and difficulty walking. She
reported a subjective weight loss over the previous month.
She had a previous history of major depressive disorder
with anxiety, chronic back pain, alcohol dependence in
partial remission, 70 pack year smoking history, alcohol
withdrawal seizures, hypertension, herniated nucleus pul-
posus of cervical, thoracic and lumbar spine, cerebrovas-
cular accident at 35 years of age and narcotic dependence.
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Her past surgical history revealed bilateral mastectomy for
fibrocystic disease with reconstructive surgery, total knee
replacement, bilateral cataract surgeries, right knee
arthroscopy with meniscus repair, appendectomy, tonsil-
lectomy, cervical and lumber spine fusion, as well as vag-
inal hysterectomy with bilateral salpingo-oopherectomy
for non-cancerous reasons at age 36. Her father died of
myocardial infarction at age 52, brother died of myocar-
dial infarction and her mother with Paget's disease of the
breast. She reported having three sons with two living. Her
medications include amlodipine, oxycodone, oxycodone
and acetaminophen, diazepam, metoprolol succinate,
and aspirin. She reported taking these medicines as pre-
scribed.
One month previously, a blood test showed a serum
sodium of 121 mEq/L. The patient left the doctor's office
against medical advice, receiving no recommendations for
evaluation or therapy. When she returned later with the
same symptoms, her serum sodium level was 100 mEq/L.
The patient displayed slowed speech and some difficulty
with balance and gait. Potassium and creatinine levels
were within normal limits. She denied excessive water
ingestion or diuretic use. The patient had no evidence of
hypothyroidism, heart failure or adrenal insufficiency.
Urine osmolality was 413 and serum osmolality was 213.
A chest CT showed a 4.1 × 4.9 cm precarinal/pretracheal
mass encircling the right brachiocephalic vein.
The patient was treated with gentle saline infusion and
low doses of intravenous furosemide with frequent mon-
itoring of electrolytes. Her treatment was later amended to
fluid restriction after her sodium rose. On successive days
her serum sodium was 113 mEq/L, 125 mEq/L and 132
mEq/L respectively and it was noted that the patient's neu-
rologic symptoms quickly resolved. The patient was dis-
charged on the fifth day with a serum sodium of 133 mEq/
L and instructed to restrict free water intake to 900 cc/day.
A biopsy at mediastinoscopy revealed a malignant, inter-
mediate-size small cell (oat cell) carcinoma. Radiation
and chemotherapy was initiated. Later, the patient unfor-
tunately died from complications related to her cancer
and therapy.
The causes of hyponatremia vary widely, from pharmaco-
logical to physiological factors. Neuroendocrine tumors
may cause hyponatremia. Narcotics have also been impli-
cated as a cause of hyponatremia; one patient recovered
from a narcotic-induced hyponatremia of 108 mEq/L [6].
We believe that hyponatremia in this patient was a result
of her neuroendocrine tumor perhaps augmented by her
use of narcotics.
Serum sodium levels of 100 mEq/L or lower are extremely
rare in the literature. One schizophrenic patient with
polydipsia died with a serum sodium of 92 mEq/L [7].
Survival has been reported in patients whose serum
sodium levels were 86 mEq/L [8], 101 mEq/L [5] and 103
mEq/L [9].
Conclusion
In general, correction of hyponatremia should be done
slowly to avoid osmotic demyelination. However, more
rapid correction may be warranted in symptomatic
patients, for example those with seizure or coma. For
treating severe, symptomatic hyponatremia, infusion of
hypertonic saline or saline combined with furosemide,
with frequent monitoring of sodium levels, has been rec-
ommended. Asymptomatic or mild hyponatremia can be
treated with fluid restriction or with demeclocycline
(though this is expensive) while a cause and definitive
treatment are sought. This paper illustrates two important
points: 1) extreme hyponatremia may develop with sur-
prisingly few symptoms if it occurs over a prolonged
period of time and 2) even very severe hyponatremia may
be successfully corrected – though in this case, the patient
had an associated disease process that was later fatal.
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